W.G. Shaheen & Associates Dba Whitney & CO Bridge Bio Pharma, Inc. Transaction History
W.G. Shaheen & Associates Dba Whitney & CO
- $963 Million
- Q2 2025
A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 12,000 shares of BBIO stock, worth $537,720. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,000
-0.0%
Holding current value
$537,720
Previous $414,000
25.12%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
381Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$988 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$863 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$668 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$558 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$321 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.64B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...